Technical Analysis for INDV - Indivior PLC
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New Downtrend | Bearish | 0.00% | |
| Jack-in-the-Box Bearish | Bearish Swing Setup | 0.00% | |
| Calm After Storm | Range Contraction | 0.00% | |
| Earnings Movers | Other | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Expansion Breakdown | Bearish Swing Setup | 1.91% | |
| Earnings Movers | Other | 1.91% | |
| Below Lower BB | Weakness | 1.91% | |
| Gapped Down | Weakness | 1.91% |
| Alert | Time |
|---|---|
| Up 3% | 1 day ago |
| Possible Inside Day | 1 day ago |
| 60 Minute Opening Range Breakout | 1 day ago |
| 2x Volume Pace | 1 day ago |
| 1.5x Volume Pace | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 04/25/2024
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Drugs Euphoriants Psychoactive Drugs Opioids Schizophrenia Morphinans Drug Rehabilitation Buprenorphine Opioid Use Disorder Sodium Channel Blockers
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Drugs Euphoriants Psychoactive Drugs Opioids Schizophrenia Morphinans Drug Rehabilitation Buprenorphine Opioid Use Disorder Sodium Channel Blockers
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 24.8999 |
| 52 Week Low | 14.3809 |
| Average Volume | 145,766 |
| 200-Day Moving Average | 19.68 |
| 50-Day Moving Average | 20.42 |
| 20-Day Moving Average | 19.79 |
| 10-Day Moving Average | 18.65 |
| Average True Range | 0.73 |
| RSI (14) | 31.97 |
| ADX | 25.61 |
| +DI | 15.77 |
| -DI | 35.24 |
| Chandelier Exit (Long, 3 ATRs) | 20.35 |
| Chandelier Exit (Short, 3 ATRs) | 19.30 |
| Upper Bollinger Bands | 22.50 |
| Lower Bollinger Band | 17.08 |
| Percent B (%b) | 0.09 |
| BandWidth | 27.34 |
| MACD Line | -0.75 |
| MACD Signal Line | -0.47 |
| MACD Histogram | -0.2777 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 18.42 | ||||
| Resistance 3 (R3) | 18.40 | 18.09 | 18.28 | ||
| Resistance 2 (R2) | 18.09 | 17.88 | 18.11 | 18.23 | |
| Resistance 1 (R1) | 17.84 | 17.75 | 17.97 | 17.86 | 18.19 |
| Pivot Point | 17.53 | 17.53 | 17.60 | 17.55 | 17.53 |
| Support 1 (S1) | 17.28 | 17.32 | 17.41 | 17.30 | 16.97 |
| Support 2 (S2) | 16.97 | 17.19 | 16.99 | 16.93 | |
| Support 3 (S3) | 16.72 | 16.97 | 16.88 | ||
| Support 4 (S4) | 16.74 |
